Apply to Graduate School | Library | Jobs & Volunteers | Visitor Information | Department Index | News      
Department of Physiology and Pharmacology

click here for Faculty | click here for Associate Faculty

Adjunct Faculty

Adjunct faculty members are appointed to the Department of Physiology & Pharmacology from business and industry for colloboration with faculty and to complement the teaching and research activities of the department.

Azeez Aileru, Ph.D., WSSU, Associate Professor; North Carolina Central University, B.S., M.S. (1986, 1990); Howard University, Ph. D. (1995) - Neurophysiology of hypertension

Jonathan Atkins, Ph.D., DABT, Associate Professor; Ph.D.; M.S. Toxicology University of Arizona Tucson(1991); Ph.D. Environmental Toxicology University of Arizona Tucson (1995); Manager, Regulatory Toxicology Syngenta Crop Protection Inc

Merouane Bencherif, M.D., Ph.D., Targacept

Kenneth Blum, Ph.D.

Charles B. Breckenridge, Ph.D., Syngenta

Gary Byrd, Ph.D., RJR

William E. Caldwell, Ph.D., Targacept

Huw M.L. Davies, Ph.D.

J. Donald DeBethizy, Ph.D., Targacept

Paolo B. DePetrillo, M.D., Applied Pharmacogenomics, LLC

David J. Doolittle, Ph.D., Associate Professor; University of Wisconsin, B.S., Biology, 1976; Michigan State University, Ph.D., Pharmacology and Toxicology, 1981; American Board of Toxicology, Diplomat, 1985; American Board of Toxicology, Recertified as a Diplomat, 1990; Master Scientist and Manager, Cellular/Molecular Biology Division, Research & Development, R.J. Reynolds Tobacco Company., Winston-Salem, NC

Wanda R. Fields, Ph.D., RJR

Ronald Fleming, Pharm.D. , GlaxoSmithKline

Kathleen Grant, Ph.D., Professor, Oregon Health Sciences University

Vladimir Grinevich, M.D., Ph.D, Associate Professor; Senior Scientist Preclinical Research, Targacept, Inc.

Jill Harp, Ph.D., WSSU, Associate Professor; York College-CUNY, B.S. Chemistry, 1985; University of Maryland-College Park, Ph.D., Organic Chemistry, 1991 - The Harp lab is involved in the synthesis and biological testing of compounds that will eradicate or alleviate neuronal disorders. Conventional and computational methods are also employed to direct the synthesis of promising drug candidates.

Gary M. Hellmann, Ph.D., Associate Professor; Centre College, B.S., Biology, 1974; University of Kentucky, M.S. 1976; University of Kentucky, Ph.D., 1988; Wake Forest University, MBA, 1997

Kristen Jordan, Ph.D., Targacept

Carol A. Knight, Ph.D., William Wrigley Jr Company

Mark L. Laudenslager, Ph.D., University of Colorado Health Sciences

Patrick M. Lippiello, Ph.D., Targacept

Brian Marable, Ph.D., Assistant Professor; University of Michigan, Neurotoxicology, 1997; Product Toxicologist, Syngenta Crop Protection, Greensboro, NC

Robert C. MacPhail, Ph.D., EPA

Craig H. Miller, Ph.D., Targacept

Richard C. Peffer, Ph.D., Associate Professor; University of Pittsburgh, Ph.D., Pharmacology & Toxicology (1986); Senior Toxicologist Syngenta Crop Protection, Inc.

Walter S. Pritchard, Ph.D., Associate Professor; Ohio State University, B.A., 1974; California State University, M.A., Psychology, 1977; University of Cincinnati, Ph.D., Psychology, 1982 ; Senior Behavioral Scientist, Biobehavioral Research and Development, R.J. Reynolds Tobacco Company, Winston-Salem, NC

Gernot Riedel, Ph.D., University of Aberdeen, Scotland

John Robinson, Ph.D., Assistant Professor; Providence College, B.A. Psychology 1970; State University of New York, Ph.D. Physiological Psychology 1976.; Senior Staff R& D Scientist with R. J. Reynolds Tobacco Co., Winston-Salem, NC - Research interest in the Physiological and Pharmacological effects of nicotine and human smoking behavior.

Jeffrey D. Schmitt, Ph.D., Targacept

Carr J. Smith, Ph.D., Entegrion, Inc

Darrell Sumner, Ph.D., Associate Professor; University of Kansas, B.A., Chemistry 1963; University of Kansas, Ph.D., Medicinal Chemistry 1968; Certification: Diplomat, American Board of Toxicology 1980; Manager, Health and Safety Issues, Department of Environmental and Public Affairs, Ciba Geigy, Inc., Greensboro, NC - Dr. Sumner's primary interest lies in the risk assessment of chemical hazards to man and the environment. A major focus occurs with pesticides (risks to workers as well as consumers), but this includes both natural products as well as pesticides since in many cases the absence of pesticides results in higher concentrations of more toxic natural products.

Can Bora Unal, M.D., Ph.D., Ion Technologies, Inc

Kent E. Vrana, Ph.D. , Penn State College of Medicine